Skip to main content
PRIMR23 SBER23 Main banner
Icon Legend
Presentation Icons
Pre-Reg Required
Pre-Reg Required
Additional Fee
Additional Fee
Livestreaming Session Icon
Livestreaming Session Icon
Live Session Recorded
Live Session Recorded
On-Demand Session
On-Demand Session
CIP Accredited
CIP Accredited
CPIA Accredited
CPIA Accredited
Call for Session Proposal
Call for Session Proposal
Human Subjects Research
Human Subjects Research
IACUC/Animal Care and Use
IACUC/Animal Care and Use
Crossover
Crossover
Institutional Leadership
Institutional Leadership
Workshop Series
Workshop Series
Thought Leader Series
Thought Leader Series
Deep Dive Series
Deep Dive Series
Learning Lab Series
Learning Lab Series
Networking Series
Networking Series
Vendor Insight Series
Vendor Insight Series
Pillars of PRIM&R Poster Award
Pillars of PRIM&R Poster Award
Poster Icons
Record Session Icon
Record Session Icon
Pre-Reg Required
Pre-Reg Required
Part I/II
Part I/II
CSP Icon
CSP Icon
Livestreaming Session Icon
Livestreaming Session Icon
Prerecorded Session Icon
Prerecorded Session Icon
CIP Accredited
CIP Accredited
Pillars Icon
Pillars Icon
Back
View Video

2023 PRIM&R Annual Conference

Pharma/Biotech Perspectives

Emerging Research Challenges and Breaking Issues

G01 - [IN-PERSON/RECORDED] Look Who's Doing Research Now! What Does it Mean for Walgreens, Walmart, Etc., to Be Conducting Human Subjects Research?

Wednesday, December 6, 2023
11:30 AM – 12:30 PM ET
Location: Room 145 AB
Live Session Recorded Human Subjects Research Call for Session Proposal Deep Dive Series CIP Accredited
This session will be offered in-person and recorded for on-demand access by in-person PRIMR23 attendees registered for this day, and PRIMR23/SBER23 Virtual Meeting registrants.

In the past two years, numerous national chains entered the clinical trials game. What does this mean? Who is conducting these studies? Where are they originating? What regulatory oversight is there? How is research being informed by the communities participating in these studies? Is this decentralization making the participant pool more diverse? What training do these researchers receive? How are participants protected? Why are these corporations now conducting HSR? Are clinical trials now a retail product? This session will explore these issues and more.

Learning Objectives:

  • Discuss clinical trial diversification
  • Review the challenges with conducting clinical trials
  • Oversight and training of clinical trials